Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

UTHR

United Therapeutics Corp

Sep 20 • 04:00PM ET

353.00

Dollar change +1.67
Percentage change 0.48	%

Healthcare • Biotechnology • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VTI IJH VB VBR VXF XBI COWZ MDY IBB SPMD

Index	-	P/E	16.22	EPS (ttm)	21.77	Insider Own	1.75%	Shs Outstand	47.04M	Perf Week	4.09%
Market Cap	15.70B	Forward P/E	12.52	EPS next Y	28.19	Insider Trans	-48.32%	Shs Float	43.71M	Perf Month	0.40%
Income	1.07B	PEG	0.92	EPS next Q	6.52	Inst Own	104.85%	Short Float	9.35%	Perf Quarter	11.69%
Sales	2.62B	P/S	6.00	EPS this Y	24.05%	Inst Trans	1.02%	Short Ratio	8.18	Perf Half Y	48.99%
Book/sh	128.25	P/B	2.75	EPS next Y	14.72%	ROA	15.96%	Short Interest	4.09M	Perf Year	57.64%
Cash/sh	66.79	P/C	5.29	EPS next 5Y	17.60%	ROE	19.25%	52W Range	208.62 - 366.08	Perf YTD	60.53%
Dividend Est.	-	P/FCF	17.83	EPS past 5Y	8.15%	ROI	18.45%	52W High	-3.57%	Beta	0.57
Dividend TTM	-	Quick Ratio	4.18	Sales past 5Y	8.02%	Gross Margin	88.85%	52W Low	69.20%	ATR (14)	8.39
Dividend Ex-Date	-	Current Ratio	4.35	EPS Y/Y TTM	22.46%	Oper. Margin	48.28%	RSI (14)	58.10	Volatility	2.24% 2.19%
Employees	1168	Debt/Eq	0.09	Sales Y/Y TTM	23.96%	Profit Margin	40.87%	Recom	2.12	Target Price	362.18
Option/Short	Yes / Yes	LT Debt/Eq	0.02	EPS Q/Q	11.81%	Payout	0.00%	Rel Volume	1.76	Prev Close	351.33
Sales Surprise	3.33%	EPS Surprise	-9.79%	Sales Q/Q	19.85%	Earnings	Jul 31 BMO	Avg Volume	499.39K	Price	353.00
SMA20	1.18%	SMA50	4.51%	SMA200	30.66%	Trades		Volume	878,358	Change	0.48%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-11-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$310 → $321
Feb-12-24	Upgrade	Goldman	Sell → Neutral	$213 → $215
Feb-05-24	Initiated	Leerink Partners	Outperform	$330
Dec-08-23	Initiated	Wells Fargo	Overweight	$309
Dec-06-22	Initiated	UBS	Buy	$320
Dec-05-22	Initiated	Goldman	Sell	$230
Oct-11-22	Initiated	Morgan Stanley	Overweight	$288
Sep-20-22	Reiterated	BofA Securities	Underperform
Sep-19-22	Resumed	Wedbush	Outperform	$263
Feb-11-22	Initiated	BTIG Research	Neutral
Jul-14-21	Upgrade	Argus	Hold → Buy	$205
Apr-26-21	Resumed	Credit Suisse	Outperform	$196
Feb-01-21	Upgrade	H.C. Wainwright	Neutral → Buy	$125 → $195
Sep-14-20	Resumed	JP Morgan	Overweight	$142
Jun-25-20	Reiterated	H.C. Wainwright	Neutral	$85 → $125
Mar-10-20	Upgrade	Jefferies	Hold → Buy	$123
Feb-27-20	Upgrade	Cowen	Market Perform → Outperform	$119 → $145
Jan-31-20	Upgrade	JP Morgan	Neutral → Overweight	$120
Dec-03-19	Initiated	BofA/Merrill	Underperform
Aug-01-19	Upgrade	Ladenburg Thalmann	Neutral → Buy	$103 → $106

Show Previous Ratings

Sep-10-24 07:00AM	United Therapeutics Publishes its 2024 Corporate Responsibility and Public Benefit Report Highlighting its Progress Toward a Future Where No Patient Gets Left BehindEver (Business Wire)
Aug-30-24 12:02PM	United Therapeutics Shares Thrive (FX Empire)
11:31AM	United Therapeutics (UTHR) Up 9.9% Since Last Earnings Report: Can It Continue? (Zacks)
Aug-28-24 07:00AM	United Therapeutics Corporation to Present at Upcoming Investor Conferences (Business Wire)
Aug-22-24 07:01PM	Insider Sale: Director Christopher Causey Sells Shares of United Therapeutics Corp (UTHR) (GuruFocus.com)
07:08PM	Loading…
Aug-21-24 07:08PM	Analyst Report: United Therapeutics Corporation (Morningstar Research)
Aug-20-24 06:33AM	Liquidias YUTREPIA inhalation powder gains tentative FDA approval (Pharmaceutical Technology)
Aug-19-24 04:01PM	Why Liquidia Stock Just Reversed Its Seven-Day Sprint And Crashed 31% (Investor's Business Daily) +8.60%
Aug-05-24 07:01PM	Insider Sale: Director Raymond Dwek Sells 5,000 Shares of United Therapeutics Corp (UTHR) (GuruFocus.com)
Aug-04-24 01:33PM	3 Biotech Stocks on Track for 50% Returns (or More) by 2028 (InvestorPlace)
Aug-02-24 12:00PM	United Therapeutics (UTHR) is a Great Momentum Stock: Should You Buy? (Zacks)
09:45AM	Here's Why United Therapeutics (UTHR) is a Strong Growth Stock (Zacks)
Aug-01-24 10:41AM	Stock Market Reverses Lower; Shake Shack, Meta Platforms Lead, But 3 Growth Stocks Hit Danger Zone (Live Coverage) (Investor's Business Daily)
01:06AM	Decoding United Therapeutics Corp (UTHR): A Strategic SWOT Insight (GuruFocus.com)
Jul-31-24 11:39PM	Analyst Report: United Therapeutics Corporation (Morningstar Research) -7.18%
04:14PM	Loading…
04:14PM	IBD 50's United Therapeutics Slumps From Its Record High On Mixed Quarter (Investor's Business Daily)
12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook United Therapeutics (UTHR) (Zacks)
09:51AM	United Therapeutics (UTHR) Q2 Earnings Lag, Sales Top Estimates (Zacks)
09:50AM	Here's Why United Therapeutics (UTHR) is a Strong Momentum Stock (Zacks)
09:30AM	United Therapeutics (UTHR) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
09:17AM	United Therapeutics Stock Skids On Mixed Second-Quarter Results (Investor's Business Daily)
07:40AM	United Therapeutics (UTHR) Misses Q2 Earnings Estimates (Zacks)
06:47AM	United Therapeutics: Q2 Earnings Snapshot (Associated Press Finance)
06:30AM	United Therapeutics Corporation Reports Second Quarter 2024 Financial Results (Business Wire)
Jul-30-24 09:40AM	Here's Why United Therapeutics (UTHR) is a Strong Value Stock (Zacks)
Jul-26-24 09:49AM	Implied Volatility Surging for United Therapeutics (UTHR) Stock Options (Zacks)
Jul-24-24 07:00AM	United Therapeutics Corporation to Report Second Quarter 2024 Financial Results Before the Market Opens on Wednesday, July 31, 2024 (Business Wire)
Jul-20-24 11:42AM	Meet some of the world's cleanest pigs, raised to grow kidneys and hearts for humans (Associated Press Finance)
Jul-17-24 09:45AM	Why United Therapeutics (UTHR) is a Top Growth Stock for the Long-Term (Zacks)
Jul-15-24 09:04PM	3 Biotech Stocks to Buy Now: Q3 Edition (InvestorPlace)
12:45PM	Loading…
12:45PM	Is United Therapeutics (UTHR) a Solid Growth Stock? 3 Reasons to Think 'Yes' (Zacks)
12:00PM	What Makes United Therapeutics (UTHR) a Strong Momentum Stock: Buy Now? (Zacks)
09:15AM	United Therapeutics Corporation (UTHR) Hit a 52 Week High, Can the Run Continue? (Zacks)
Jul-12-24 09:40AM	Why United Therapeutics (UTHR) is a Top Value Stock for the Long-Term (Zacks)
Jul-11-24 09:50AM	Why United Therapeutics (UTHR) is a Top Momentum Stock for the Long-Term (Zacks)
09:02AM	United Therapeutics (UTHR) Completes Enrolment in IPF Study (Zacks)
04:52AM	United Therapeutics TETON 2 study achieves full enrolment for IPF treatment (Clinical Trials Arena)
Jul-10-24 07:00AM	United Therapeutics Corporation Announces Full Enrollment of the TETON 2 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis (Business Wire)
Jul-09-24 12:10PM	Will United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Jul-08-24 11:23AM	3 Undervalued Stocks on Track to Double (or More) by 2028 (InvestorPlace)
Jul-01-24 02:18PM	7 Undervalued Biotech Stocks to Buy for Big-Time Returns (InvestorPlace)
Jun-28-24 10:36AM	Big Money Elevating United Therapeutics (FX Empire)
Jun-27-24 07:00AM	United Therapeutics Corporation Announces Election of Jan Malcolm to its Board of Directors (Business Wire)
Jun-26-24 03:02PM	Why United Therapeutics, An IBD 50 Stock, Has Surged 36% Over Nine Weeks (Investor's Business Daily)
09:40AM	Here's Why United Therapeutics (UTHR) is a Strong Value Stock (Zacks)
Jun-21-24 03:10AM	Insider Sale: Director Christopher Causey Sells Shares of United Therapeutics Corp (UTHR) (GuruFocus.com)
Jun-20-24 03:58PM	The 3 Best Medical Device Stocks to Buy in June 2024 (InvestorPlace)
Jun-18-24 07:00PM	Insider Sale: Director Judy Olian Sells Shares of United Therapeutics Corp (UTHR) (GuruFocus.com)
Jun-14-24 07:00PM	Insider Sale: Director Christopher Causey Sells Shares of United Therapeutics Corp (UTHR) (GuruFocus.com)
Jun-07-24 09:40AM	Why United Therapeutics (UTHR) is a Top Value Stock for the Long-Term (Zacks)
Jun-05-24 07:00AM	United Therapeutics Corporation to Present at the Goldman Sachs 45th Annual Global Healthcare Conference (Business Wire)
Jun-04-24 02:18PM	The 3 Most Undervalued Healthcare Stocks to Buy in June 2024 (InvestorPlace)
Jun-03-24 04:33PM	Liquidia Stock Surges After Winning Patent Battle Vs. United Therapeutics (Investor's Business Daily)
May-31-24 11:31AM	Why Is United Therapeutics (UTHR) Up 4.8% Since Last Earnings Report? (Zacks)
May-30-24 09:50AM	Here's Why United Therapeutics (UTHR) is a Strong Momentum Stock (Zacks)
May-27-24 10:11AM	3 Underappreciated Biotech Stocks to Buy Now: May 2024 (InvestorPlace)
May-23-24 09:45AM	Here's Why United Therapeutics (UTHR) is a Strong Growth Stock (Zacks)
May-22-24 09:40AM	Here's Why United Therapeutics (UTHR) is a Strong Value Stock (Zacks)
04:56AM	Latest 340B ruling delivers blow to providers (Healthcare Dive)
May-20-24 01:34PM	7 Biotech Stocks That Could Breathe New Life Into Your Portfolio (InvestorPlace)
May-16-24 07:01PM	Insider Sale: Director Christopher Causey Sells Shares of United Therapeutics Corp (UTHR) (GuruFocus.com)
07:01PM	Insider Sale: CFO and Treasurer James Edgemond Sells 40,160 Shares of United Therapeutics Corp ... (GuruFocus.com)
May-15-24 02:05AM	Q1 2024 Liquidia Corp Earnings Call (Thomson Reuters StreetEvents)
May-14-24 04:39PM	United Therapeutics Insider Sold Shares Worth $1,911,532, According to a Recent SEC Filing (MT Newswires)
May-10-24 04:41PM	United Therapeutics Insider Sold Shares Worth $1,898,393, According to a Recent SEC Filing (MT Newswires)
May-09-24 11:47AM	MannKind Corporation (NASDAQ:MNKD) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-08-24 05:15PM	United Therapeutics Insider Sold Shares Worth $949,737, According to a Recent SEC Filing (MT Newswires)
09:50AM	Why United Therapeutics (UTHR) is a Top Momentum Stock for the Long-Term (Zacks)
May-07-24 05:00PM	United Therapeutics Insider Sold Shares Worth $1,871,233, According to a Recent SEC Filing (MT Newswires)
02:23AM	Insider Sale: Director Judy Olian Sells Shares of United Therapeutics Corp (UTHR) (GuruFocus.com)
02:23AM	Insider Sale: Director Christopher Causey Sells Shares of United Therapeutics Corp (UTHR) (GuruFocus.com)
May-06-24 04:43PM	United Therapeutics Insider Sold Shares Worth $2,585,601, According to a Recent SEC Filing (MT Newswires)
02:30PM	3 Biotech Stocks to Double Your Money in the Next 24 Months (InvestorPlace)
12:45PM	United Therapeutics (UTHR) is an Incredible Growth Stock: 3 Reasons Why (Zacks)
09:45AM	Here's Why United Therapeutics (UTHR) is a Strong Growth Stock (Zacks)
09:15AM	United Therapeutics Corporation (UTHR) Hits Fresh High: Is There Still Room to Run? (Zacks)
May-05-24 08:19AM	Bright Horizons Family Solutions Inc. (NYSE:BFAM) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-03-24 07:50PM	Analyst Report: United Therapeutics Corporation (Morningstar Research)
04:39PM	United Therapeutics Insider Sold Shares Worth $1,829,903, According to a Recent SEC Filing (MT Newswires)
02:41PM	30 Most Profitable Companies with Highest Margins in the World (Insider Monkey)
May-02-24 11:59AM	United Therapeutics (UTHR) Q1 Earnings Top, Tyvaso Drives Sales (Zacks)
11:43AM	United Therapeutics Corporation (NASDAQ:UTHR) Q1 2024 Earnings Call Transcript (Insider Monkey)
11:35AM	UBS Adjusts Price Target on United Therapeutics to $300 From $290, Maintains Buy Rating (MT Newswires)
09:54AM	Oppenheimer Adjusts United Therapeutics Price Target to $400 From $375, Maintains Outperform Rating (MT Newswires)
03:12AM	United Therapeutics Corp (UTHR) Q1 2024 Earnings Call Transcript Highlights: Record Revenue and ... (GuruFocus.com)
01:06AM	Decoding United Therapeutics Corp (UTHR): A Strategic SWOT Insight (GuruFocus.com)
12:07AM	Q1 2024 United Therapeutics Corp Earnings Call (Thomson Reuters StreetEvents)
May-01-24 04:35PM	Lung Disease-Focused United Therapeutics Says It Is A Compelling Investment Opportunity (Benzinga) +8.88%
09:30AM	Compared to Estimates, United Therapeutics (UTHR) Q1 Earnings: A Look at Key Metrics (Zacks)
08:46AM	United Therapeutics Q1 Net Income, Revenue Advance; Shares Rise Pre-Bell (MT Newswires)
07:51AM	United Therapeutics Surpasses Analyst Revenue Forecasts with Strong Q1 2024 Performance (GuruFocus.com)
06:35AM	United Therapeutics: Q1 Earnings Snapshot (Associated Press Finance)
06:30AM	United Therapeutics Corporation Reports First Quarter 2024 Financial Results (Business Wire)
Apr-29-24 12:00PM	What Makes United Therapeutics (UTHR) a New Buy Stock (Zacks)
Apr-26-24 02:02PM	CORRECTING and REPLACING PHOTO United Therapeutics Announces Worlds First Successful Xenothymokidney Transplant (Business Wire)
Apr-24-24 12:10PM	Will United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report? (Zacks)
10:01AM	United Therapeutics (UTHR) Earnings Expected to Grow: Should You Buy? (Zacks)
09:00AM	United Therapeutics Announces Worlds First Successful Xenothymokidney Transplant (Business Wire)
07:00AM	United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024 (Business Wire)
Apr-23-24 04:39PM	United Therapeutics Insider Sold Shares Worth $1,704,174, According to a Recent SEC Filing (MT Newswires)

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Olian Judy D.	Director	Sep 17 '24	Option Exercise	112.14	2,300	257,922	9,705	Sep 17 04:30 PM
EDGEMOND JAMES	CFO AND TREASURER	Sep 16 '24	Option Exercise	118.99	8,334	991,622	7,140	Sep 17 04:30 PM
EDGEMOND JAMES	CFO AND TREASURER	Sep 16 '24	Sale	339.12	7,810	2,648,527	3,740	Sep 17 04:30 PM
JUDY OLIAN	Director	Sep 17 '24	Proposed Sale	353.22	2,300	812,406		Sep 17 04:04 PM
JAMES EDGEMOND	Officer	Sep 16 '24	Proposed Sale	339.12	7,810	2,648,527		Sep 16 04:20 PM
EDGEMOND JAMES	CFO AND TREASURER	Sep 09 '24	Option Exercise	118.98	8,332	991,381	6,610	Sep 10 04:30 PM
EDGEMOND JAMES	CFO AND TREASURER	Sep 09 '24	Sale	345.41	7,802	2,694,889	3,210	Sep 10 04:30 PM
JAMES EDGEMOND	Officer	Sep 09 '24	Proposed Sale	345.41	7,802	2,694,889		Sep 09 04:14 PM
PATUSKY CHRISTOPHER	Director	Sep 04 '24	Option Exercise	175.43	4,300	754,349	5,200	Sep 05 04:30 PM
PATUSKY CHRISTOPHER	Director	Sep 03 '24	Option Exercise	175.43	700	122,801	1,600	Sep 05 04:30 PM
PATUSKY CHRISTOPHER	Director	Sep 04 '24	Sale	353.36	4,300	1,519,434	900	Sep 05 04:30 PM
PATUSKY CHRISTOPHER	Director	Sep 03 '24	Sale	360.31	700	252,214	900	Sep 05 04:30 PM
EDGEMOND JAMES	CFO AND TREASURER	Sep 03 '24	Option Exercise	118.98	8,332	991,381	6,015	Sep 04 04:34 PM
EDGEMOND JAMES	CFO AND TREASURER	Sep 03 '24	Sale	362.37	7,785	2,821,050	2,615	Sep 04 04:34 PM
CHRISTOPHER PATUSKY	Director	Sep 04 '24	Proposed Sale	353.36	4,300	1,519,434		Sep 04 04:14 PM
CHRISTOPHER PATUSKY	Director	Sep 03 '24	Proposed Sale	360.31	700	252,214		Sep 03 04:35 PM
JAMES EDGEMOND	Officer	Sep 03 '24	Proposed Sale	362.37	7,785	2,821,050		Sep 03 04:18 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 26 '24	Option Exercise	129.49	269	34,833	399	Aug 28 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 26 '24	Sale	348.41	269	93,723	130	Aug 28 04:30 PM
EDGEMOND JAMES	CFO AND TREASURER	Aug 26 '24	Option Exercise	118.98	8,332	991,381	5,482	Aug 26 04:30 PM
EDGEMOND JAMES	CFO AND TREASURER	Aug 26 '24	Sale	347.60	7,799	2,710,932	2,082	Aug 26 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 22 '24	Option Exercise	129.49	3,600	466,164	3,730	Aug 26 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 23 '24	Option Exercise	129.49	3,600	466,164	3,730	Aug 26 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 23 '24	Sale	348.11	3,600	1,253,198	130	Aug 26 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 22 '24	Sale	346.82	3,600	1,248,567	130	Aug 26 04:30 PM
JAMES EDGEMOND	Officer	Aug 26 '24	Proposed Sale	347.60	7,799	2,710,932		Aug 26 04:24 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 20 '24	Option Exercise	129.49	3,600	466,164	3,730	Aug 22 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 21 '24	Option Exercise	129.49	3,600	466,164	3,730	Aug 22 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 21 '24	Sale	350.14	3,600	1,260,496	130	Aug 22 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 20 '24	Sale	346.03	3,600	1,245,698	130	Aug 22 04:30 PM
CAUSEY CHRISTOPHER	Director	Aug 21 '24	Option Exercise	132.30	1,210	160,083	5,395	Aug 22 04:30 PM
CAUSEY CHRISTOPHER	Director	Aug 21 '24	Sale	349.00	1,210	422,290	4,185	Aug 22 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 19 '24	Option Exercise	129.49	3,600	466,164	3,730	Aug 21 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 19 '24	Sale	344.18	3,600	1,239,047	130	Aug 21 04:30 PM
CHRISTOPHER CAUSEY	Director	Aug 21 '24	Proposed Sale	349.00	1,210	422,290		Aug 21 04:05 PM
EDGEMOND JAMES	CFO AND TREASURER	Aug 19 '24	Option Exercise	118.98	8,332	991,381	4,978	Aug 20 04:30 PM
EDGEMOND JAMES	CFO AND TREASURER	Aug 19 '24	Sale	329.02	7,828	2,575,569	1,578	Aug 20 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 15 '24	Option Exercise	129.49	3,600	466,164	3,730	Aug 19 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 16 '24	Option Exercise	129.49	3,600	466,164	3,730	Aug 19 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 15 '24	Sale	323.32	3,600	1,163,965	130	Aug 19 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 16 '24	Sale	320.68	3,600	1,154,432	130	Aug 19 04:30 PM
JAMES EDGEMOND	Officer	Aug 19 '24	Proposed Sale	329.02	7,828	2,575,569		Aug 19 04:25 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 13 '24	Option Exercise	129.49	3,600	466,164	3,730	Aug 15 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 14 '24	Option Exercise	129.49	3,600	466,164	3,730	Aug 15 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 13 '24	Sale	327.84	3,600	1,180,221	130	Aug 15 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 14 '24	Sale	324.50	3,600	1,168,205	130	Aug 15 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 09 '24	Option Exercise	129.49	3,600	466,164	3,730	Aug 13 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 12 '24	Option Exercise	129.49	3,600	466,164	3,730	Aug 13 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 12 '24	Sale	334.14	3,600	1,202,909	130	Aug 13 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 09 '24	Sale	330.48	3,600	1,189,712	130	Aug 13 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 07 '24	Option Exercise	129.49	3,600	466,164	3,730	Aug 09 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 08 '24	Option Exercise	129.49	3,600	466,164	3,730	Aug 09 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 08 '24	Sale	328.39	3,600	1,182,205	130	Aug 09 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 07 '24	Sale	324.01	3,600	1,166,437	130	Aug 09 04:30 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Aug 07 '24	Option Exercise	118.41	25,000	2,960,200	20,000	Aug 08 04:30 PM
BENKOWITZ MICHAEL	PRESIDENT AND COO	Aug 07 '24	Sale	323.38	25,000	8,084,473	0	Aug 08 04:30 PM
M BENKOWITZ & M R BENKOWITZ CO	Officer	Aug 07 '24	Proposed Sale	323.37	20,000	6,467,448		Aug 07 05:17 PM
DANIEL CARLSON TTEE BENKOWITZ	Officer	Aug 07 '24	Proposed Sale	323.40	5,000	1,617,024		Aug 07 05:16 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 05 '24	Option Exercise	129.49	3,600	466,164	3,730	Aug 07 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 06 '24	Option Exercise	129.49	3,600	466,164	3,730	Aug 07 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 06 '24	Sale	325.45	3,600	1,171,625	130	Aug 07 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 05 '24	Sale	321.64	3,600	1,157,916	130	Aug 07 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 01 '24	Option Exercise	129.49	3,600	466,164	3,730	Aug 05 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 02 '24	Option Exercise	129.49	3,600	466,164	3,730	Aug 05 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 02 '24	Sale	324.73	3,600	1,169,043	130	Aug 05 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Aug 01 '24	Sale	323.91	3,600	1,166,066	130	Aug 05 04:30 PM
DWEK RAYMOND	Director	Aug 02 '24	Option Exercise	175.43	5,000	877,150	6,750	Aug 05 04:30 PM
DWEK RAYMOND	Director	Aug 02 '24	Sale	325.35	5,000	1,626,735	1,750	Aug 05 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 31 '24	Option Exercise	129.49	3,600	466,164	3,730	Aug 02 05:13 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 31 '24	Sale	318.39	3,600	1,146,210	130	Aug 02 05:13 PM
RAYMOND DWEK	Director	Aug 02 '24	Proposed Sale	325.35	5,000	1,626,734		Aug 02 04:08 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 29 '24	Option Exercise	129.49	3,600	466,164	3,730	Jul 31 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 30 '24	Option Exercise	129.49	3,600	466,164	3,730	Jul 31 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 30 '24	Sale	337.40	3,600	1,214,630	130	Jul 31 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 29 '24	Sale	335.72	3,600	1,208,605	130	Jul 31 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 25 '24	Option Exercise	129.49	3,600	466,164	3,730	Jul 29 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 26 '24	Option Exercise	129.49	3,600	466,164	3,730	Jul 29 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 25 '24	Sale	338.89	3,600	1,219,999	130	Jul 29 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 26 '24	Sale	338.61	3,600	1,219,011	130	Jul 29 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 23 '24	Option Exercise	129.49	3,600	466,164	3,730	Jul 25 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 24 '24	Option Exercise	129.49	3,600	466,164	3,730	Jul 25 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 23 '24	Sale	335.38	3,600	1,207,368	130	Jul 25 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 24 '24	Sale	334.00	3,600	1,202,414	130	Jul 25 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 19 '24	Option Exercise	129.49	3,600	466,164	3,730	Jul 23 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 22 '24	Option Exercise	129.49	3,600	466,164	3,730	Jul 23 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 22 '24	Sale	331.32	3,600	1,192,738	130	Jul 23 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 19 '24	Sale	329.59	3,600	1,186,506	130	Jul 23 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 17 '24	Option Exercise	129.49	3,600	466,164	3,730	Jul 19 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 18 '24	Option Exercise	129.49	3,600	466,164	3,730	Jul 19 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 17 '24	Sale	333.69	3,600	1,201,298	130	Jul 19 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 18 '24	Sale	331.79	3,600	1,194,438	130	Jul 19 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 15 '24	Option Exercise	129.49	3,600	466,164	3,730	Jul 17 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 16 '24	Option Exercise	129.49	3,600	466,164	3,730	Jul 17 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 16 '24	Sale	328.03	3,600	1,180,909	130	Jul 17 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 15 '24	Sale	326.29	3,600	1,174,636	130	Jul 17 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 11 '24	Option Exercise	129.49	3,600	466,164	3,730	Jul 15 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 12 '24	Option Exercise	129.49	3,600	466,164	3,730	Jul 15 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 11 '24	Sale	325.96	3,600	1,173,470	130	Jul 15 04:30 PM
ROTHBLATT MARTINE A	Chairperson & CEO	Jul 12 '24	Sale	324.97	3,600	1,169,875	130	Jul 15 04:30 PM
PATUSKY CHRISTOPHER	Director	Jul 13 '24	Option Exercise	0.00	900	0	900	Jul 15 04:30 PM

Open in Screener

DOC

Healthpeak Properties Inc.

Sep 20 • 04:00PM ET

22.01

Dollar change +0.11
Percentage change 0.50	%

Real Estate • REIT - Healthcare Facilities • USA • NYSE

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

DOC Healthpeak Properties Inc. daily Stock Chart

Held by: VNQ VTI VOO VB SPY IVV VO VBR RSP XLRE

Index	S&P 500	P/E	47.37	EPS (ttm)	0.46	Insider Own	0.35%	Shs Outstand	699.29M	Perf Week	-2.52%
Market Cap	15.39B	Forward P/E	94.81	EPS next Y	0.23	Insider Trans	0.00%	Shs Float	696.82M	Perf Month	0.55%
Income	287.14M	PEG	-	EPS next Q	0.06	Inst Own	93.17%	Short Float	1.48%	Perf Quarter	14.40%
Sales	2.41B	P/S	6.38	EPS this Y	-39.50%	Inst Trans	-1.78%	Short Ratio	2.14	Perf Half Y	23.51%
Book/sh	12.51	P/B	1.76	EPS next Y	-31.49%	ROA	1.60%	Short Interest	10.33M	Perf Year	10.60%
Cash/sh	0.23	P/C	96.62	EPS next 5Y	-12.59%	ROE	3.76%	52W Range	15.24 - 22.79	Perf YTD	11.16%
Dividend Est.	1.20 (5.45%)	P/FCF	17.93	EPS past 5Y	-24.23%	ROI	1.61%	52W High	-3.42%	Beta	1.12
Dividend TTM	1.20 (5.45%)	Quick Ratio	-	Sales past 5Y	5.92%	Gross Margin	23.28%	52W Low	44.42%	ATR (14)	0.40
Dividend Ex-Date	Aug 05, 2024	Current Ratio	-	EPS Y/Y TTM	-52.12%	Oper. Margin	18.92%	RSI (14)	50.49	Volatility	2.18% 1.72%
Employees	193	Debt/Eq	1.04	Sales Y/Y TTM	13.99%	Profit Margin	11.91%	Recom	1.63	Target Price	24.07
Option/Short	Yes / Yes	LT Debt/Eq	1.04	EPS Q/Q	119.34%	Payout	215.83%	Rel Volume	2.30	Prev Close	21.90
Sales Surprise	4.57%	EPS Surprise	109.79%	Sales Q/Q	27.51%	Earnings	Jul 25 AMC	Avg Volume	4.84M	Price	22.01
SMA20	-0.88%	SMA50	1.52%	SMA200	12.89%	Trades		Volume	11,123,509	Change	0.50%

Date	Action	Analyst	Rating Change	Price Target Change
May-03-24	Upgrade	Wedbush	Neutral → Outperform
Apr-26-24	Upgrade	Exane BNP Paribas	Neutral → Outperform	$19 → $21
Apr-22-24	Resumed	Mizuho	Buy	$22
Apr-01-24	Upgrade	BofA Securities	Underperform → Buy	$18 → $25
Mar-25-24	Resumed	Wells Fargo	Equal Weight	$19
Mar-08-24	Resumed	RBC Capital Mkts	Outperform	$21
Jan-05-24	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
May-26-23	Initiated	JMP Securities	Mkt Outperform	$15.50
Apr-20-23	Initiated	Wells Fargo	Underweight	$14
Dec-14-22	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$17
Oct-28-22	Initiated	JP Morgan	Neutral	$17
Aug-05-22	Downgrade	Colliers Securities	Buy → Neutral	$19
Jun-03-22	Initiated	CapitalOne	Equal Weight	$20
May-19-22	Downgrade	BofA Securities	Neutral → Underperform	$18
Apr-26-22	Initiated	Barclays	Overweight	$20
Feb-01-22	Initiated	Credit Suisse	Neutral	$19
Jan-07-22	Downgrade	BMO Capital Markets	Outperform → Market Perform	$20
Sep-13-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$20
Aug-20-21	Downgrade	Raymond James	Outperform → Mkt Perform
Jun-14-21	Downgrade	Robert W. Baird	Outperform → Neutral	$19 → $20

Show Previous Ratings

Sep-13-24 12:15PM	How the 10-year yield affects REITs (Yahoo Finance Video)
Sep-11-24 12:10PM	Analyst Report: Healthpeak Properties, Inc. (Morningstar Research)
Aug-23-24 07:14PM	Analyst Report: Healthpeak Properties, Inc. (Morningstar Research)
Aug-19-24 12:00PM	Healthpeak (DOC) Upgraded to Buy: Here's What You Should Know (Zacks)
Jul-26-24 11:04AM	Analyst Report: Healthpeak Properties, Inc. (Morningstar Research) +5.49%
04:15PM	Loading…
Jul-25-24 04:15PM	Healthpeak Properties Reports Second Quarter 2024 Results and Declares Quarterly Cash Dividend on Common Stock (Business Wire)
Jul-22-24 02:00PM	How To Earn $500 Per Month From Healthpeak Properties (Benzinga)
Jul-12-24 09:22AM	Is It Wise to Hold Healthpeak Properties (DOC) Stock Now? (Zacks)
Jun-27-24 03:52PM	Analyst Report: Healthpeak Properties, Inc. (Morningstar Research)
Jun-24-24 05:43PM	Analyst Report: Healthpeak Properties, Inc. (Morningstar Research)
Jun-20-24 04:15PM	Healthpeak Properties Announces Second Quarter 2024 Earnings Release Date and Conference Call Details (Business Wire)
Jun-19-24 06:45AM	DOC, VZ, APAM: 6% Dividend-Yielding Bargains to Buy Now (InvestorPlace)
Jun-13-24 04:15PM	Healthpeak Properties Publishes Its 13th Annual Corporate Impact Report (Business Wire)
May-30-24 04:15PM	Healthpeak Properties to Present at Nareit's REITweek 2024 Investor Conference (Business Wire)
May-07-24 04:15PM	Healthpeak Properties Announces Joint Venture Wind-Down (Business Wire)
03:07AM	Loading…
Apr-27-24 03:07AM	Healthpeak Properties Inc (DOC) (Q1 2024) Earnings Call Transcript Highlights: Strategic Growth ... (GuruFocus.com)
01:05AM	Decoding Healthpeak Properties Inc (DOC): A Strategic SWOT Insight (GuruFocus.com)
Apr-26-24 04:07PM	Analyst Report: Healthpeak Properties, Inc. (Morningstar Research)
Apr-25-24 04:15PM	Healthpeak Properties Reports First Quarter 2024 Results and Declares Quarterly Cash Dividend on Common Stock (Business Wire)
Apr-04-24 04:15PM	Healthpeak Properties Announces First Quarter 2024 Earnings Release Date and Conference Call Details (Business Wire)
Mar-04-24 02:06PM	Analyst Report: Healthpeak Properties, Inc. (Morningstar Research)
Feb-26-24 06:04PM	American Homes 4 Rent Set to Join S&P MidCap 400 (PR Newswire)
04:15PM	Healthpeak Properties, Inc. and Healthpeak OP, LLC Complete Consent Solicitation and Offers to Guarantee and Receive Required Consents to Amend Physicians Realty L.P. Indentures (Business Wire)
Feb-21-24 08:00PM	Here's What Key Metrics Tell Us About Physicians Realty Trust (DOC) Q4 Earnings (Zacks)
07:10PM	Physicians Realty Trust (DOC) Meets Q4 FFO Estimates (Zacks)
06:18PM	Physicians Realty Trust: Q4 Earnings Snapshot (Associated Press Finance)
05:33PM	Physicians Realty Trust (DOC) Reports Mixed Q4 Results Amid Merger Developments (GuruFocus.com)
05:00PM	Physicians Realty Trust Reports Fourth Quarter and Year Ended 2023 Financial Results (Business Wire)
05:00PM	Healthpeak Properties Stockholders and Physicians Realty Trust Shareholders Approve Merger (Business Wire)
Feb-12-24 08:28AM	Healthpeak Properties, Inc. and Healthpeak OP, LLC Commence Consent Solicitation and Offers to Guarantee for Physicians Realty L.P. Senior Notes (Business Wire)
08:32AM	Loading…
Feb-10-24 08:32AM	Healthpeak Properties, Inc. (NYSE:PEAK) Q4 2023 Earnings Call Transcript (Insider Monkey)
Jan-27-24 12:07PM	SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates FNCB, PWFL, DOC, GRPH (GlobeNewswire)
Jan-26-24 12:12PM	Kuehn Law Encourages DOC, BATL, KAMN, and INBX Investors to Contact Law Firm (PR Newswire)
Jan-09-24 04:02PM	2024's Rough Start: More Than A Half Dozen REITs Get Downgrades (Benzinga)
Jan-01-24 11:03AM	Physicians Realty Trust's Dividend Analysis (GuruFocus.com)
Dec-21-23 07:00AM	Physicians Realty Trust Declares Quarterly Cash Dividend for the Fourth Quarter 2023 (Business Wire)
Nov-09-23 09:44AM	7 Dividend Stocks for Daring Investors Who Want to Make Bank (InvestorPlace)
06:14AM	These 2 Healthcare Stocks Are Merging Is It a Buying Opportunity? (Motley Fool)
Nov-07-23 01:52PM	Moore Kuehn Encourages SRC, MIRO, DOC, and SIX Investors to Contact Law Firm (PR Newswire)
Nov-02-23 06:23AM	Should You Buy Physicians Realty Trust Before It Merges With Healthpeak? (Motley Fool) +8.02%
05:35AM	You Can't Control Company Mergers, But You Can Control What You Do About Them (Motley Fool)
Nov-01-23 11:46AM	Healthpeak Properties, Inc. (NYSE:PEAK) Q3 2023 Earnings Call Transcript (Insider Monkey)
10:12AM	Moore Kuehn Encourages CSTR, DOC, EAR, and SRC Investors to Contact Law Firm (GlobeNewswire)
Oct-31-23 09:13PM	Physicians Realty Trust (DOC) Reports Q3 2023 Earnings: Net Income Down 80.6% YoY (GuruFocus.com)
07:40AM	A Mega Acquisition Makes This 7.7%-Yielding Dividend Stock Even Healthier (Motley Fool)
Oct-30-23 12:17PM	Healthpeak Properties and Physicians Realty Are Merging in a Busy Day for REIT Deals (Barrons.com)
11:31AM	It's Merger Monday for Real-Estate Investment Trusts (The Wall Street Journal)
09:30AM	Compared to Estimates, Physicians Realty Trust (DOC) Q3 Earnings: A Look at Key Metrics (Zacks)
08:15AM	Physicians Realty Trust (DOC) Matches Q3 FFO Estimates (Zacks)
07:30AM	Healthpeak Properties, Physicians Realty Trust to Merge in $21B Deal (The Wall Street Journal)
07:17AM	UPDATE 3-Healthpeak to merge with Physicians Realty to create $21 bln firm (Reuters)
07:09AM	Physicians Realty Trust: Q3 Earnings Snapshot (Associated Press Finance)
07:05AM	HealthPeak to merge with Physicians Realty to create $21 billion entity (Reuters)
06:59AM	Physicians Realty Trust Reports Third Quarter 2023 Financial Results (Business Wire)
06:59AM	Healthpeak Properties and Physicians Realty Trust to Combine in an All-Stock Merger of Equals to Create the Pre-Eminent Owner, Operator and Developer of Real Estate for Healthcare Discovery and Delivery, An Attractive and Growing Market (Business Wire)
Oct-02-23 07:02AM	Physicians Realty Trust (DOC): A Deep Dive into the Dividend Performance (GuruFocus.com)
Sep-21-23 06:00AM	Physicians Realty Trust Declares Quarterly Cash Dividend and Announces Date for the Third Quarter 2023 Earnings Release and Conference Call (Business Wire)
Sep-15-23 01:05AM	Insider Sell: Laurie Becker Sells 22,322 Shares of Physicians Realty Trust (DOC) (GuruFocus.com)
Sep-13-23 09:08PM	Insider Buying: Director Albert Black Acquires 2,264 Shares of Physicians Realty Trust (DOC) (GuruFocus.com)
Aug-26-23 07:47AM	3 Top Stocks You Can Still Buy for Under $20 a Share (Motley Fool)
Aug-03-23 10:00AM	Compared to Estimates, Physicians Realty Trust (DOC) Q2 Earnings: A Look at Key Metrics (Zacks)
09:05AM	Physicians Realty Trust (DOC) Meets Q2 FFO Estimates (Zacks)
07:59AM	Physicians Realty Trust: Q2 Earnings Snapshot (Associated Press Finance)
07:52AM	Physicians Realty Trust Reports Second Quarter 2023 Financial Results (Business Wire)
Jul-24-23 05:45PM	Alexandria Real Estate Equities (ARE) Tops Q2 FFO and Revenue Estimates (Zacks)
08:41AM	3 High-Yield Healthcare Stocks to Boost Your Passive Income Stream (Motley Fool)
Jul-19-23 06:00AM	Physicians Realty Trust Celebrates 10 Years in Business on July 19, 2023 (Business Wire)
Jul-11-23 10:00AM	RTG Partners with Northside Hospital and Physicians Realty Trust on 100,000 SF Gwinnett Medical Office Building (PR Newswire)
Jul-05-23 05:13AM	Want $6,000 in Annual Dividend Income? Invest $64,200 in These 3 High-Yield Stocks. (Motley Fool)
Jul-03-23 09:37PM	Dividend Powerhouses: 7 Stocks to Outrun Inflation and Grow Your Wealth (InvestorPlace)
Jun-21-23 08:00PM	DOC: Lowering target price to $15.00 (Argus Research)
Jun-16-23 07:45AM	Physicians Realty Trust Declares Quarterly Cash Dividend and Announces Date for the Second Quarter 2023 Earnings Release and Conference Call (Business Wire)
Jun-05-23 07:15AM	Physicians Realty Trust Publishes Fourth Annual ESG Report (Business Wire)
May-24-23 05:45PM	Physicians Realty Trust Announces $400 Million Five-Year Term Loan (Business Wire)
May-16-23 05:13AM	3 Exceptional Dividend Stocks That Retirees Should Love (Motley Fool)
May-05-23 01:42AM	Q1 2023 Physicians Realty Trust Earnings Call (Thomson Reuters StreetEvents)
May-04-23 09:30AM	2 Healthcare REITs to Consider Buying on the Dip (Motley Fool)
09:05AM	Physicians Realty Trust (DOC) Misses Q1 FFO Estimates (Zacks)
08:02AM	Physicians Realty Trust: Q1 Earnings Snapshot (AP Finance)
07:51AM	Physicians Realty Trust Reports First Quarter 2023 Financial Results (Business Wire)
May-02-23 05:45PM	Extra Space Storage (EXR) Misses Q1 FFO and Revenue Estimates (Zacks)
Apr-26-23 08:00PM	DOC: Lowering target price to $15.00 (Argus Research)
Apr-24-23 05:13AM	Want $4,000 in Annual Dividend Income? Invest $45,000 in These 2 High-Yield Stocks. (Motley Fool)
Mar-28-23 10:05AM	Physicians Realty Trust Earns 2023 ENERGY STAR Partner of the Year Award (Business Wire)
Mar-27-23 08:07AM	Kilroy Realty (KRC) Soars 6.0%: Is Further Upside Left in the Stock? (Zacks)
Mar-21-23 10:21AM	2 Better Healthcare REITs Than Medical Properties Trust (Motley Fool)
Mar-17-23 07:00AM	Physicians Realty Trust Declares Quarterly Cash Dividend and Announces Date for the First Quarter 2023 Earnings Release and Conference Call (Business Wire)
Mar-15-23 07:03AM	With EPS Growth And More, Physicians Realty Trust (NYSE:DOC) Makes An Interesting Case (Simply Wall St.)
Mar-08-23 08:06AM	12 Dividend Giants with Lowest Short Interest (Insider Monkey)
Mar-01-23 04:01AM	Heres Why ClearBridge Small Cap Strategy Exited Physicians Realty Trust (DOC) (Insider Monkey)
Feb-23-23 04:32PM	Physicians Realty Trust (NYSE:DOC) Q4 2022 Earnings Call Transcript (Insider Monkey)
Feb-22-23 09:05AM	Physicians Realty Trust (DOC) Q4 FFO Match Estimates (Zacks)
07:51AM	Physicians Realty Trust Reports Fourth Quarter 2022 Financial Results (Business Wire)
Feb-16-23 09:10AM	Want to Get Richer? 2 Dividend Stocks to Buy Now and Hold Forever (Motley Fool)
Jan-27-23 08:30AM	Got $5,000? These 3 Dividend Stocks Are Yielding More Than 5% (Motley Fool)
Jan-21-23 09:15AM	Is Now a Good Time to Invest in a Medical REIT? (Motley Fool)
Jan-13-23 03:57PM	Analysts Just Upgraded These 3 Healthcare REITs (Benzinga)
Jan-02-23 07:24AM	Should Weakness in Physicians Realty Trust's (NYSE:DOC) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? (Simply Wall St.)
Dec-22-22 05:00AM	Physicians Realty Trust Declares Quarterly Cash Dividend and Announces Date for the Fourth Quarter 2022 Earnings Release and Conference Call (Business Wire)
Dec-04-22 08:39PM	10 Stocks Under $25 to Buy Now (Insider Monkey)

Healthpeak Properties, Inc. is a Standard & Poor's 500 company, which engages in acquiring, developing, owning, leasing, and managing healthcare real estate across the United States. It operates through the following segments: Lab, Outpatient Medical, Continuing Care Retirement Community (CCRC), and Other Non-Reportable. The Lab segment refers to lab properties, which contain laboratory and office space. The Outpatient Medical segment includes outpatient medical buildings and hospitals. The CCRC segment deals with retirement communities that include independent living, assisted living, memory care, and skilled nursing units. The Other Non-Reportable segment consists of an unconsolidated joint venture with a sovereign wealth fund that owns 19 senior housing assets and loans receivable. The company was founded in 1985 and is headquartered in Denver, CO.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hall Amy M	SVP-Leasing&Physician Strategy	Dec 08 '23	Sale	12.58	4,001	50,333	35,824	Dec 12 04:10 PM

UTHR

United Therapeutics Corp

DOC

Healthpeak Properties Inc.

Upgrade your FINVIZ experience